Stock Events

Stock Events

BridgeBio Oncology Therapeutics 

$8.55
0
+$0+0% Monday 02:32

Statistics

Day High
8.58
Day Low
8.55
52W High
-
52W Low
-
Volume
144
Avg. Volume
-
Mkt Cap
684.28M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2025
Q4 2025
Next
-1.03
-0.81
-0.6
-0.38
Expected EPS
-0.5233
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-268.09MNet Income

Analyst Ratings

$23.83Average Price Target
The highest estimate is 29.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBOT.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a subsidiary of BridgeBio Pharma, it focuses on precision oncology with a pipeline that includes BBO-8520, BBO-10203, and BBO-11818 programs targeting KRAS and PI3K pathways. The company recently went public through a business combination with Helix Acquisition Corp. II, raising approximately $450 million to advance clinical development. The CEO is Dr. Eli Wallace, and the CSO is Dr. Pedro Beltran.
Show more...
CEO
ISIN
US1079241022

Listings

XNAS
US
BBOT
BOATS
BOATS
BBOT.BOATS

0 Comments

Share your thoughts

FAQ

What is BridgeBio Oncology Therapeutics stock price today?▼
The current price of BBOT.BOATS is $8.55 USD — it has increased by +0% in the past 24 hours. Watch BridgeBio Oncology Therapeutics stock price performance more closely on the chart.
What is BridgeBio Oncology Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BridgeBio Oncology Therapeutics stocks are traded under the ticker BBOT.BOATS.
What is BridgeBio Oncology Therapeutics market cap?▼
Today BridgeBio Oncology Therapeutics has the market capitalization of 684.28M
When is the next BridgeBio Oncology Therapeutics earnings date?▼
BridgeBio Oncology Therapeutics is going to release the next earnings report on June 03, 2026.
What were BridgeBio Oncology Therapeutics earnings last quarter?▼
BBOT.BOATS earnings for the last quarter are -0.49 USD per share, whereas the estimation was -0.63 USD resulting in a +22.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BridgeBio Oncology Therapeutics revenue for the last year?▼
BridgeBio Oncology Therapeutics revenue for the last year amounts to 0 USD.
What is BridgeBio Oncology Therapeutics net income for the last year?▼
BBOT.BOATS net income for the last year is -268.09M USD.
When did BridgeBio Oncology Therapeutics complete a stock split?▼
BridgeBio Oncology Therapeutics has not had any recent stock splits.